IV Contrast Media Shortage

The Food and Drug Administration (FDA) continues to report shortages of GE Healthcare’s Omnipaque™ (iohexol) and iodixanol intravenous contrast media products for computed tomography imaging. In an April 19, 2022, letter to customers, GE Healthcare said it was rationing orders for its iohexol products after a COVID-19 lockdown temporarily shut down its production facility for iodinated contrast media in Shanghai, China.

The Supply Chain Resource Council (SCRC) has issued a special report highlighting the expanding shortage of GE Healthcare contrast media. Included in the SCRC report are conservation tactics from the field that we are sharing to inform your strategies.

Download the SCRC Report

More information:



Receive AHRMM Updates